Home
Learn More
Release Features
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
May 13, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
 
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
Close Move
All Press Releases for May 7, 2008 Subscribe to this News Feed      
 

Biorisk-Free Growth Factors Now Available to the Cosmeceutical Industry to Meet Growing Demand for Safe Anti-Aging Ingredients

ORF Genetics' green technology offers safety and security to cosmetic formulators and ingredient industry worldwide.

Reykjavik, Iceland (PRWEB) May 7, 2008 -- ORF Genetics, headquartered in Reykjavik, Iceland, announced that they have introduced the next generation of growth factors to the cosmetic industry. These biorisk-free growth factors for professional skin care products are shown to have great potential as anti-aging agents.

Marketed under the brand name ISOkine™, ORF's growth factors are produced utilizing the company's Orfeus™ plant-based expression platform, ensuring products of excellent purity, safety and bioactivity. The ISOkine™ product is a unique alternative to growth factors produced from bacterial or animal-based production platforms, as ORF's plant-based system provides a more safe, "green" and cost effective option, while eliminating any potential risk of toxins or contaminants.    

Our Orfeus™ plant-based production system is an elegant, futuristic approach for producing growth factors guaranteed to be endotoxin-free -- a feature that is becoming as critical to a cosmeceutical company as it is today to a stem cell researcher
An increasing number of cosmetic companies are using recombinant growth factors in their formulations and product development, based on the growing consumer demand for effective anti-aging products. ORF Genetics recently exhibited their biorisk-free products for the first time at the In-Cosmetics show in Amsterdam, and the response was fantastic, according to Dr. Bjorn Orvar, ORF Genetics' CEO. "Since our core emphasis is on the medical research community, and we are active working with stem cell products and diagnostics, the cosmetic industry sees us as highly credible in their market as well," stated Dr. Orvar. "Our Orfeus™ plant-based production system is an elegant, futuristic approach for producing growth factors guaranteed to be endotoxin-free -- a feature that is becoming as critical to a cosmeceutical company as it is today to a stem cell researcher", continued Dr. Orvar.

The Orfeus system utilizes the barley grain -- a natural, environmentally friendly production host -- to manufacture pure, untainted growth factors. The plants are grown in a soilless hydroponic system housed in a huge state-of-the-art greenhouse, which runs on renewable geothermal energy, set out in the Icelandic lava fields. Since barley is considered G.R.A.S. (Generally Recognized As Safe) according to FDA standards, and the growth factors are rigorously tested for quality and efficacy, ORF's products provide additional assurance to the cosmetic industry that the products are safe and effective for use in cosmetic formulations.

Due to the scalability of the Orfeus™ production system, ORF Genetics will be able to supply large-scale, bulk quantities of ISOkine™ growth factors to the cosmetic market at a very competitive price.

ORF will be exhibiting their products in the US at the upcoming Supplier's Day Show hosted by the New York Society for Cosmetic Chemists in May.

Those interested in purchasing or learning more about the ISOkine™ growth factor line can contact the company through ORF Genetics' web site.

About ORF Genetics
Headquartered in Reykjavik, Iceland ORF Genetics Ltd. is a privately owned biotech company that is committed to economically viable, green technology for the production of growth factors and hard to produce recombinant proteins. Utilizing its unique Orfeus™ plant based expression system, the company is currently producing biorisk-free, high purity ISOkine™ products to serve the needs of the medical research, cell culture media, diagnostics and cosmetic markets. ORF was recently awarded the prestigious 2008 Icelandic Innovation Award by the Icelandic Center for Research and the Icelandic Trade Council. The annual award is given to a single Icelandic company that is pioneering research and development.

Contact:
Bjorn Larus Orvar, Ph.D.
CEO, ORF Genetics
Keldnaholt
IS-112 Reykjavik
Iceland
+354 591 1570
+354 821 1573
www.orfgenetics.com

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/SW5zZS1DcmFzLUhhbGYtRW1wdC1DcmFzLVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Digg | Furl It | Spurl | RawSugar | Simpy | Shadows | Blink It | My Web



OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareIt

Share The News

Submit this press release easily to any of these major bookmarking and social media sites.

CONTACT INFORMATION
Bjorn Larus Orvar, Ph.D.
ORF Genetics
+354 591 1570
Email us Here
ATTACHED FILES

Press Release Attachment

Press Release Attachment
ORF Genetics logo

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright